The deliveries of the inactivated whole-virion vaccine to the international market will be possible only after Russia fully meets its needs for preventive preparations against COVID-19, Center Head Aidar Ishmukhametov said.
After weeks of research in the fight against coronavirus around the world, potential medications are starting to be tested. In Russia, the Defense Ministry has chosen 50 volunteers for clinical trials of a new Covid-19 vaccine.
“The use of levilimab at the very beginning of clinical manifestations of respiratory failure helps prevent the necessity to transfer patients to the intensive care unit.”
In Chekhonin’s opinion, a vaccine against COVID-19 should be expected by the start of the next year.